An international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocol.
BACKGROUND: Atrial fibrillation (AF) is an independent risk factor for stroke and a significant predictor of mortality. Evidence-based guidelines for stroke prevention in AF recommend antithrombotic therapy corresponding to the risk of stroke. In practice, many patients with AF do not receive the a...
Main Authors: | Apenteng, P, Murray, E, Holder, R, Hobbs, R, Fitzmaurice, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2013
|
Similar Items
-
33Patterns of antithrombotic therapy in relation to type of atrial fibrillation: insights from the UK cohort of the global GARFIELD registry.
by: Apenteng, P, et al.
Published: (2014) -
Evolving antithrombotic treatment patterns in patients with newly diagnosed atrial fibrillation: UK findings from the GARFIELD-AF registry
by: Apenteng, P, et al.
Published: (2016) -
Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry
by: Apenteng, P, et al.
Published: (2018) -
Temporal trends in antithrombotic treatment of real-world UK patients
with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry
by: Apenteng, P, et al.
Published: (2018) -
Two-year outcomes of UK patients newly diagnosed with atrial fibrillation: findings from the prospective observational cohort study GARFIELD-AF
by: Apenteng, PN, et al.
Published: (2022)